What is Haemonetics's work in process?

Haemonetics (HAE) reported work in process of $17.5M in Q4 2025.

How has Haemonetics's work in process changed year-over-year?

Haemonetics's work in process decreased by 45.5% year-over-year, from $32.12M to $17.5M.

What is the long-term trend for Haemonetics's work in process?

Over 4 years (2021 to 2025), Haemonetics's work in process has grown at a -10.3% compound annual growth rate (CAGR), from $23.11M to $14.96M.

What does work in process mean?

Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.

Haemonetics HAE Work in process

Work in process at other companies

AbbottABT

$994M+11.7%

TFX

TeleflexTFX

$53.39M-62.2%

LivaNovaLIVN

$18.1M+19.4%

ICU MedicalICUI

$48.14M+8.4%

Boston ScientificBSX

——

MedtronicMDT

——

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Operating income$67.4M+14.2%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.31B-18.0%

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's work in process?: Haemonetics (HAE) reported work in process of $17.5M in Q4 2025.
How has Haemonetics's work in process changed year-over-year?: Haemonetics's work in process decreased by 45.5% year-over-year, from $32.12M to $17.5M.
What is the long-term trend for Haemonetics's work in process?: Over 4 years (2021 to 2025), Haemonetics's work in process has grown at a -10.3% compound annual growth rate (CAGR), from $23.11M to $14.96M.
What does work in process mean?: Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.